87 related articles for article (PubMed ID: 15588896)
21. Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel.
Lee LY; Wang CH; Smith KA
J Control Release; 2008 Jan; 125(2):96-106. PubMed ID: 18054107
[TBL] [Abstract][Full Text] [Related]
22. Novel composite microparticles for protein stabilization and delivery.
Schoubben A; Blasi P; Giovagnoli S; Perioli L; Rossi C; Ricci M
Eur J Pharm Sci; 2009 Feb; 36(2-3):226-34. PubMed ID: 18950709
[TBL] [Abstract][Full Text] [Related]
23. Supercritical fluid assisted production of micrometric powders of the labile trypsin and chitosan/trypsin composite microparticles.
Shen YB; Guan YX; Yao SJ
Int J Pharm; 2015 Jul; 489(1-2):226-36. PubMed ID: 25957701
[TBL] [Abstract][Full Text] [Related]
24. Solid lipid particles for oral delivery of peptide and protein drugs I--elucidating the release mechanism of lysozyme during lipolysis.
Christophersen PC; Zhang L; Yang M; Nielsen HM; Müllertz A; Mu H
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):473-80. PubMed ID: 23911434
[TBL] [Abstract][Full Text] [Related]
25. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers.
Zidan AS; Sammour OA; Hammad MA; Megrab NA; Hussain MD; Khan MA; Habib MJ
AAPS PharmSciTech; 2006 Jul; 7(3):61. PubMed ID: 17025242
[TBL] [Abstract][Full Text] [Related]
26. Poly (DL-lactide-co-glycolide) microparticles as carriers for antimycobacterial drug rifampicin.
Dutt M; Khuller GK
Indian J Exp Biol; 2000 Sep; 38(9):887-94. PubMed ID: 12561946
[TBL] [Abstract][Full Text] [Related]
27. Drug encapsulation using supercritical fluid extraction of emulsions.
Chattopadhyay P; Huff R; Shekunov BY
J Pharm Sci; 2006 Mar; 95(3):667-79. PubMed ID: 16447174
[TBL] [Abstract][Full Text] [Related]
28. Encapsulation of protein drugs in biodegradable microparticles by co-axial electrospray.
Xie J; Ng WJ; Lee LY; Wang CH
J Colloid Interface Sci; 2008 Jan; 317(2):469-76. PubMed ID: 17945246
[TBL] [Abstract][Full Text] [Related]
29. Stable cationic microparticles for enhanced model antigen delivery to dendritic cells.
Wischke C; Borchert HH; Zimmermann J; Siebenbrodt I; Lorenzen DR
J Control Release; 2006 Sep; 114(3):359-68. PubMed ID: 16889866
[TBL] [Abstract][Full Text] [Related]
30. Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
Bouchard A; Jovanović N; de Boer AH; Martín A; Jiskoot W; Crommelin DJ; Hofland GW; Witkamp GJ
Eur J Pharm Biopharm; 2008 Sep; 70(1):389-401. PubMed ID: 18534833
[TBL] [Abstract][Full Text] [Related]
31. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying.
Clarke N; O'Connor K; Ramtoola Z
Drug Dev Ind Pharm; 1998 Feb; 24(2):169-74. PubMed ID: 15605447
[TBL] [Abstract][Full Text] [Related]
32. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
Della Porta G; Reverchon E
Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
[TBL] [Abstract][Full Text] [Related]
33. Preliminary evaluation of polymer-based drug composite microparticle production by coacervate desolvation with supercritical carbon dioxide.
Yasuji T; Haslam J; Kajiyama A; McIntosh MP; Rajewski RA
J Pharm Sci; 2006 Mar; 95(3):581-8. PubMed ID: 16419052
[TBL] [Abstract][Full Text] [Related]
34. How to achieve sustained and complete protein release from PLGA-based microparticles?
Giteau A; Venier-Julienne MC; Aubert-Pouëssel A; Benoit JP
Int J Pharm; 2008 Feb; 350(1-2):14-26. PubMed ID: 18162341
[TBL] [Abstract][Full Text] [Related]
35. Glycol chitosan as a stabilizer for protein encapsulated into poly(lactide-co-glycolide) microparticle.
Lee ES; Park KH; Park IS; Na K
Int J Pharm; 2007 Jun; 338(1-2):310-6. PubMed ID: 17363202
[TBL] [Abstract][Full Text] [Related]
36. The role of branched polyesters and their modifications in the development of modern drug delivery vehicles.
Dailey LA; Wittmar M; Kissel T
J Control Release; 2005 Jan; 101(1-3):137-49. PubMed ID: 15588900
[TBL] [Abstract][Full Text] [Related]
37. Effect of nanoprecipitation on the physicochemical properties of low molecular weight poly(L-lactic acid) nanoparticles loaded with salbutamol sulphate and beclomethasone dipropionate.
Hyvönen S; Peltonen L; Karjalainen M; Hirvonen J
Int J Pharm; 2005 May; 295(1-2):269-81. PubMed ID: 15848011
[TBL] [Abstract][Full Text] [Related]
38. An investigation of the factors controlling the adsorption of protein antigens to anionic PLG microparticles.
Chesko J; Kazzaz J; Ugozzoli M; O'hagan DT; Singh M
J Pharm Sci; 2005 Nov; 94(11):2510-9. PubMed ID: 16200615
[TBL] [Abstract][Full Text] [Related]
39. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
40. Supercritical antisolvent precipitation of PHBV microparticles.
Costa MS; Duarte AR; Cardoso MM; Duarte CM
Int J Pharm; 2007 Jan; 328(1):72-7. PubMed ID: 16971075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
